NeuClone Makes Progress On Ustekinumab

Reports Positive Phase I Results; Phase III Trial To Begin In 2021

 
• By David Wallace
  
Clinical Trial
NeuClone is pushing ahead with its clinical trials for ustekinumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products